Skip to main content
FinSpry Logo
FinSpry
CTXR logo
CTXR
(NASDAQ)
Citius Pharmaceuticals, Inc.
$0.86-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Citius Pharmaceuticals (CTXR) Stock Price & Financial Analysis

Citius Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.78 - $0.86
52-Week High$2.48
52-Week Low$0.63
Open$0.85
Volume399.87K
Average Volume (3M)252.94K
Market Cap18.48M
Shares Outstanding21.50M
Price to Sales (P/S)4.59
Price to Book (P/B)0.23
EV/EBITDA-0.33
Revenue (TTM)3.94M
Net Income (TTM)-35.89M
EPS (TTM)$-1.67
Profit Margin-909.87%
Operating Margin-950.92%
Return on Equity (ROE)-44.88%
Debt to Equity0.02
50-Day MA$0.79
200-Day MA$1.15
52-Week Change-29.74%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Citius Pharmaceuticals

What is the current stock price for CTXR?

As of the latest trading session, CTXR stock trades at $0.79. The 52-week range is $0.63–$2.48, with a day range of $0.78–$0.86.

What is the P/E ratio for CTXR?

The P/E ratio (Price-to-Earnings) for CTXR is shown in the Key Statistics section. This valuation metric helps compare Citius Pharmaceuticals, Inc. to industry peers.

Does CTXR pay dividends?

Citius Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CTXR?

Based on 1 analyst, the consensus for CTXR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CTXR?

Citius Pharmaceuticals's market capitalization is $17.0M, classifying it as a micro-cap company. Citius Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.